foxo4-dri senolytic peptide study 2017 Targeting the FOXO4-p53 axis by retro-inverso agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology Catalog-Ref: LVS618 SLU-PP-332/ 5-Amino-1MQ Capsules Strength:500 mg/mL
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12